Back to top
more

Addus HomeCare (ADUS)

(Delayed Data from NSDQ)

$133.58 USD

133.58
114,705

+1.19 (0.90%)

Updated Aug 23, 2024 03:59 PM ET

After-Market: $133.46 -0.12 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Quest Diagnostics (DGX) Ties Up With Hackensack Meridian Health

Quest Diagnostics (DGX) collaborates with Hackensack Meridian Health to manage laboratory operation and provide high-quality healthcare network.

Addus HomeCare's (ADUS) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Addus HomeCare (ADUS).

The Zacks Analyst Blog Highlights: Addus HomeCare, Fulgent Genetics and Hologic

The Zacks Analyst Blog Highlights: Addus HomeCare, Fulgent Genetics and Hologic

3 MedTech Growth Stocks With Solid Prospects for 2021

Here are a few MedTech growth stocks poised for a rebound that investors can scoop up to reap profits going into 2021.

Aparajita Dutta headshot

Bet on These 5 Low Leverage Stocks to Avoid Portfolio Losses

Debt financing is desirable as long as the companies succeed in generating a higher rate of return compared to the interest rate. You may consider adding TITN, SAIA, BCC, ODP, ADUS in your portfolio

Is Addus HomeCare (ADUS) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Addus HomeCare (ADUS).

Quest Diagnostics (DGX) Soars to 52-Week High, Time to Cash Out?

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

ADUS vs. AMED: Which Stock Is the Better Value Option?

ADUS vs. AMED: Which Stock Is the Better Value Option?

Addus HomeCare Sees Hammer Chart Pattern: Time to Buy?

Addus HomeCare has been struggling lately, but the selling pressure may be coming to an end soon.

Debanjana Dey headshot

3 Affordable MedTech Growth Stocks to Buy Amid Market Unrest

Here are some MedTech stocks which might be a solid investment option amid the coronavirus-battered market conditions.

Healthcare for Silver Years to Aid Encompass Health (EHC)

Encompass Health's (EHC) inpatient rehabilitation and home hospice businesses are poised to grow on the back of aging population.

Encompass Health to Build Rehabilitation Hospital in Illinois

Encompass Health (EHC) plans to build a rehabilitation facility in Illinois to serve the local community. The healthcare home will be launched in 2022 spring and complement other units in the area.

ADUS vs. USPH: Which Stock Is the Better Value Option?

ADUS vs. USPH: Which Stock Is the Better Value Option?

3 Reasons Growth Investors Will Love Addus HomeCare (ADUS)

Addus HomeCare (ADUS) could produce exceptional returns because of its solid growth attributes.

ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Is Addus HomeCare (ADUS) a Solid Growth Stock? 3 Reasons to Think " Yes "

Addus HomeCare (ADUS) could produce exceptional returns because of its solid growth attributes.

Top Ranked Momentum Stocks to Buy for January 21st

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st.

What Makes Addus HomeCare (ADUS) a Strong Momentum Stock: Buy Now?

Does Addus HomeCare (ADUS) have what it takes to be a top stock pick for momentum investors? Let's find out.

DGX or ADUS: Which Is the Better Value Stock Right Now?

DGX vs. ADUS: Which Stock Is the Better Value Option?

3 Reasons Why Addus HomeCare (ADUS) Is a Great Growth Stock

Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.

Addus HomeCare (ADUS) Surpasses Q3 Earnings and Revenue Estimates

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 6.90% and 5.37%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights: NRG, AquaVenture, Addus, Amedisys and Bluerock Residential

The Zacks Analyst Blog Highlights: NRG, AquaVenture, Addus, Amedisys and Bluerock Residential

Nalak Das headshot

5 Top Stocks to Gain From Fed's Stable Monetary Stance

Fed was compelled to reduce it in three consecutive and equal tranches of 25 basis points to sustain the expansion of the U.S. economy.

Addus HomeCare (ADUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Looking for a Growth Stock? 3 Reasons Why Addus HomeCare (ADUS) is a Solid Choice

Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.